Literature DB >> 22729340

Adrenal insufficiency secondary to inappropriate oral administration of topical exogenous steroids presenting with hypercalcaemia.

Rahila Sarwar Bhatti1, Michael D Flynn.   

Abstract

A 59-year-old Caucasian gentleman presented with malaise, fatigue and proximal muscle weakness. He had history of long-standing roseate psoriasis treated with topical clobetasol propionate (dermovate). On admission, he had significant postural hypotension, and hypercalcaemia. Endocrinological investigation revealed hypercalcaemia, a serum cortisol of <30 nmol/l, a flat short synacthen test and undetectable adrenocorticotropic hormone. He was treated with hydrocortisone. The abrupt withdrawal of the topical steroids by the patient precipitated the addisonian crisis. Further enquiry documented inappropriate oral administration of clobetasol for more than 10 years in addition to prescribed topical usage.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22729340      PMCID: PMC3387449          DOI: 10.1136/bcr.03.2012.5983

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Effect on adrenal function of topically applied clobetasol propionate (Dermovate).

Authors:  C F Allenby; R A Main; R A Marsden; C G Sparkes
Journal:  Br Med J       Date:  1975-12-13

Review 2.  Exogenous Cushing's syndrome and glucocorticoid withdrawal.

Authors:  Rachel L Hopkins; Matthew C Leinung
Journal:  Endocrinol Metab Clin North Am       Date:  2005-06       Impact factor: 4.741

3.  Adrenal suppression following low-dose topical clobetasol propionate.

Authors:  E M Ohman; S Rogers; F O Meenan; T J McKenna
Journal:  J R Soc Med       Date:  1987-07       Impact factor: 5.344

4.  Pharmacokinetics. Pharmacokinetic factors affecting epidermal penetration and percutaneous adsorption.

Authors:  S Riegelman
Journal:  Clin Pharmacol Ther       Date:  1974-11       Impact factor: 6.875

5.  Percutaneous absorption of corticosteroids: systemic effects.

Authors:  R B Scoggins; B Kliman
Journal:  N Engl J Med       Date:  1965-10-14       Impact factor: 91.245

6.  Etiology of hypercalcemia in a patient with Addison's disease.

Authors:  E Muls; R Bouillon; J Boelaert; G Lamberigts; S Van Imschoot; R Daneels; P De Moor
Journal:  Calcif Tissue Int       Date:  1982       Impact factor: 4.333

Review 7.  Optimised glucocorticoid therapy: the sharpening of an old spear.

Authors:  Frank Buttgereit; Gerd-Rüdiger Burmester; Brian J Lipworth
Journal:  Lancet       Date:  2005 Feb 26-Mar 4       Impact factor: 79.321

8.  Hypercalcaemia in Addison's disease: calciotropic hormone profile and bone histology.

Authors:  A Montoli; G Colussi; L Minetti
Journal:  J Intern Med       Date:  1992-12       Impact factor: 8.989

Review 9.  Secondary hypoadrenalism presenting with hypercalcaemia.

Authors:  S D Vasikaran; G A Tallis; W J Braund
Journal:  Clin Endocrinol (Oxf)       Date:  1994-08       Impact factor: 3.478

  9 in total
  3 in total

1.  A Case of Acute Adrenal Insufficiency: A Rare but Possible Cause of Hypercalcemia.

Authors:  Hayat Aynaou; Houda Salhi; Hanan El Ouahabi
Journal:  Cureus       Date:  2022-05-05

2.  Adrenal insufficiency presenting as hypercalcemia and acute kidney injury.

Authors:  Seung Won Ahn; Tong Yoon Kim; Sangmin Lee; Jeong Yeon Jeong; Hojoon Shim; Yu Min Han; Kyu Eun Choi; Seok Joon Shin; Hye Eun Yoon
Journal:  Int Med Case Rep J       Date:  2016-07-29

3.  Evaluation of the Increase in Serum Calcium Levels After Unilateral Adrenalectomy.

Authors:  Mehmet Üstün; Korhan Tuncer
Journal:  Cureus       Date:  2022-09-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.